| CENTER ID: | GilaA.01209.c |
| ORGANISM: | Giardia lamblia ATCC 50803 |
| ASSOCIATED DISEASE: | Giardiasis |
| CURRENT STATUS: | soluble |
| COMMUNITY REQUEST: | True |
| NIH RISK GROUP: | 2 |
| SELECT AGENT: | False |
| NIH PRIORITY pathogens category: |
IIIB |
| CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
|---|---|---|---|---|---|
| GilaA.01209.c.B1.GE42271 | full length | 1 | 697 | ||
| GilaA.01209.c.B4.GE42597 | core kinase domain plus ordered region | 15 | 286 | ||
| GilaA.01209.c.HZ4.GE42598 | core kinase domain plus ordered region | 15 | 286 |
| RESOURCE | REFERENCE ID |
|---|---|
| EuPathDB: | GiardiaDB:GL50803_112518 |
| UniProt: | A8B9W0 |
| HARVESTED ON: | 2/23/2018 |
| SEQUENCED ON: | 3/1/2018 |
| EXPECTED MW: | 77kDa |
| OBSERVED MW: | 77kDa |
| ANTIBIOTIC MARKER: | ampicillin |
| COUNT OF EXPRESSION COLONIES: | Few (1-10) |
| TOTAL EXPRESSION LEVEL: | Moderate Expression |
| SOLUBLE EXPRESSION LEVEL | Low Expression |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| SEQUENCING RESULT: | |
| PERCENT IDENTITY: | data unavailable |
| PERCENT COVERAGE: | data unavailable |
| HARVESTED ON: | 8/5/2018 |
| SEQUENCED ON: | 8/8/2018 |
| EXPECTED MW: | 31kDa |
| OBSERVED MW: | 31kDa |
| ANTIBIOTIC MARKER: | ampicillin |
| COUNT OF EXPRESSION COLONIES: | Good (10-50) |
| TOTAL EXPRESSION LEVEL: | Moderate Expression |
| SOLUBLE EXPRESSION LEVEL | Insoluble |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| SEQUENCING RESULT: | |
| PERCENT IDENTITY: | 69 |
| PERCENT COVERAGE: | 100 |
| HARVESTED ON: | data unavailable |
| SEQUENCED ON: | 8/8/2018 |
| EXPECTED MW: | 43kDa |
| OBSERVED MW: | 70kDa |
| ANTIBIOTIC MARKER: | ampicillin |
| COUNT OF EXPRESSION COLONIES: | Good (10-50) |
| TOTAL EXPRESSION LEVEL: | Moderate Expression |
| SOLUBLE EXPRESSION LEVEL | Moderate Expression |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| SEQUENCING RESULT: | |
| PERCENT IDENTITY: | 79 |
| PERCENT COVERAGE: | 99 |